{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Long-Term Efficacy of Medication-Assisted Treatment of Opioid Addiction: A Systematic Literature Review - Part 2
Activity Steps
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Purpose of Activity
To examine the evidence on long-term efficacy of medication-assisted treatment for opioid.Learning Objectives
After completing this continuing education activity you will be able to:
- Describe the efficacy of full and partial opioid agonist medication-assisted treatment (MAT) in long-term patient outcomes.
- Summarize the aggregate research evidence concerning the relative efficacy of methadone versus buprenorphine/ buprenorphine-naloxone MAT on long-term patient outcomes.
- Explain the research evidence for the efficacy for injectable antagonist MAT on long-term patient outcomes.
Disclosures
The author, faculty, and staff have no relevant financial relationships with any ineligible organizations regarding this educational activity.
Price:
$12.95
Credits:
- NAADAC 1.0 CH
Wolters Kluwer Health is a NAADAC-Approved Education Provider. Provider number 110696.
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Professions:
Addiction Counselor
Test Code: TPM0220AC
Published: Feb 2020
Expired: 10/31/2024
Required Passing Score: 8/10 (80%)
Topics:
Opioid misuse
,
Opioids